MOLÉCULES BISPÉCIFIQUES DE LIAISON À L'ANTIGÈNE COMPRENANT UN CLONE ANTI-FAP 212

The invention relates to novel bispecific antigen binding molecules, comprising (a) at least one antigen binding domain capable of specific binding to Fibroblast Activation Protein (FAP) comprising FAP clone 212 or variants thereof, and (b) at least one antigen binding domain capable of specific bin...

Full description

Saved in:
Bibliographic Details
Main Authors RAPP, Moritz, KLEIN, Christian, DUERR, Harald, LE CLECH, Marine, UMAÑA, Pablo, BRUENKER, Peter, BUJOTZEK, Alexander, ZIELONKA, Joerg, TRUMPELLER, Christine
Format Patent
LanguageFrench
Published 05.01.2022
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to novel bispecific antigen binding molecules, comprising (a) at least one antigen binding domain capable of specific binding to Fibroblast Activation Protein (FAP) comprising FAP clone 212 or variants thereof, and (b) at least one antigen binding domain capable of specific binding to CD40, and to methods of producing these molecules and to methods of using the same.
Bibliography:Application Number: MA20190053806